Annex A 
 
 
 
 
   
   
   
   
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/03/263/001 
Dukoral   
--¹ 
EU/1/03/263/002 
Dukoral   
--¹ 
EU/1/03/263/003 
Dukoral   
--¹ 
Suspension and 
effervescent 
powder for oral 
suspension 
Suspension and 
effervescent 
powder for oral 
suspension 
Suspension and 
effervescent 
powder for oral 
suspension 
Oral use 
Oral use 
Oral use 
vaccine: vial 
(glass); powder: 
sachet (PE/alu) 
vaccine: vial 
(glass); powder: 
sachet (PE/alu) 
vaccine: vial 
(glass); powder: 
sachet (PE/alu) 
vaccine: 3 ml; 
sachet: 5.6 g 
1 vial + 1 sachet  
vaccine: 3 ml; 
sachet: 5.6 g 
2 vials + 2 sachets  
vaccine: 3 ml; 
sachet: 5.6 g 
20 vials + 20 
sachets   
--¹  Each dose of vaccine suspension (3 ml) contains: 
- A total of 1.25x10¹¹ bacteria of the following strains: 
Vibrio cholerae O1 Inaba, classical biotype (heat inactivated)              31.25x109 bacteria 
Vibrio cholerae O1 Inaba, El Tor biotype (formalin inactivated) 
31.25x109 bacteria 
Vibrio cholerae O1 Ogawa, classical biotype (heat inactivated)            31.25x109 bacteria 
Vibrio cholerae O1 Ogawa, classical biotype (formalin inactivated) 
31.25x109 bacteria 
- Recombinant cholera toxin B subunit (rCTB) 1 mg 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
